Signalpoint

← Full daily brief

Mass Tort brief

Product Liability Breaches the Algorithm Barrier

A $40 million catheter verdict and landmark trials for social media and generative AI test corporate defenses from operating rooms to algorithm design.

Signalpoint TeamBrief

Mass Tort

Tech platforms cannot hide behind Section 230 immunity in court — Meta and Snap answer to product liability juries over algorithms deliberately engineered to hook teenagers.

BackgroundThousands of lawsuits consolidated in California state court argue that social media platforms deliberately engineered addictive algorithmic recommendation systems that triggered adolescent depression and self-harm. Platforms have historically claimed absolute immunity under Section 230 of the Communications Decency Act.

Points
  1. Eleventh-hour financial settlements by TikTok and YouTube narrowed the courtroom defendants to Meta and Snap just as jury selection got underway in Los Angeles.
  2. Top executive leadership, including Mark Zuckerberg, Adam Mosseri, and Evan Spiegel, are scheduled to testify regarding internal algorithmic design choices and youth retention metrics.
  3. The trial tests novel product liability theories that bypass federal Section 230 immunity by focusing strictly on defective application architecture rather than published third-party user content.
SourcesTechCentral.ie: Meta, Snap head to trial in another case about social media's harms (opens in new tab)MDL Update: Social Media Addiction Trial Begins: S.J. and K.D.B. v. Snap and Meta (Los Angeles, October 2026) (opens in new tab)

Mass Tort

Scientific causation standards defeated the baby food mass tort — federal judges dismissed hundreds of lawsuits after plaintiffs failed to prove trace dietary metals cause autism.

BackgroundParents filed hundreds of consolidated lawsuits against commercial baby food makers including Gerber and Hain Celestial after congressional reports identified trace heavy metals in purées. Toxic tort claims require admissible epidemiological evidence establishing general biological causation between exposure and diagnosed neurological conditions.

Points
  1. Judge Corley ruled plaintiffs failed to produce reliable scientific evidence demonstrating that dietary heavy metal levels in commercial purées cause autism or ADHD in children.
  2. The summary judgment victory insulates Gerber, Hain Celestial, Beech-Nut, and Walmart from multi-million-dollar damage exposure across hundreds of pending federal cases.
  3. Plaintiffs' attorneys announced plans to appeal to the 9th Circuit, arguing the district court improperly excluded peer-reviewed toxicological studies and clinical expert testimony.
SourcesTop Class Actions: Gerber, baby food makers win partial summary judgment in autism MDL (opens in new tab)

Mass Tort

A $40 million bellwether verdict broke Bard's trial defense — device maker Becton Dickinson now confronts immense settlement pressure across thousands of fractured catheter injury claims.

BackgroundImplanted port catheters are surgically placed into chemotherapy patients to deliver intravenous medications directly into major veins. Plaintiffs allege that Bard's PowerPort Groshong devices suffer structural material fatigue, fracturing and migrating dangerously into patients' hearts.

Points
  1. The jury reached a unanimous compensatory award after hearing internal evidence that silicone catheter degradation caused fragments to break loose inside the patient's bloodstream.
  2. The plaintiff required emergency open-chest surgical extraction after suffering life-threatening cardiac events, establishing severe physical harm directly attributable to the device's material failure.
  3. The $40 million award hands massive financial leverage to thousands of plaintiffs awaiting trial in the Arizona federal multidistrict litigation, forcing parent firm Becton Dickinson to reconsider settlement talks.
SourcesGlobeNewswire: Jury Awards $40 Million to Plaintiff in Bellwether Verdict in Bard Implanted Port Catheter MDL (opens in new tab)

Mass Tort

Chatbot medical disclaimers are collapsing in wrongful death litigation — OpenAI risks strict product liability for automated algorithmic advice that resulted in fatal seizures.

BackgroundCommercial AI chatbots include terms of service disclaiming professional healthcare advice, but millions of consumers treat conversational agents as personalized diagnostic tools. California Judicial Council Coordinated Proceedings established JCCP No. 5431 to manage state-level product injury claims against major AI developers.

Points
  1. The complaint asserts wrongful death and strict product liability, alleging the chatbot instructed the patient to taper prescribed epilepsy medications and skip routine blood tests.
  2. Following the conversational chatbot's instructions, the patient suffered a fatal seizure directly linked by medical examiners to subtherapeutic anti-epileptic medication levels.
  3. The legal proceeding tests whether conversational software outputs can be legally categorized as defective commercial products subject to strict tort liability rather than protected speech.
SourcesAI Weekly: Family sues OpenAI over ChatGPT advice on epilepsy drug before woman died (opens in new tab)

Unlock the full brief

Sign in to read every signal, takeaway, and source. Free account — Apple, Google, or email.

Or read free in the appDownload on the App Store